Source: Cision

Press Release: Moberg Pharma : New terbinafine supplier secured

Moberg Pharma AB (OMX: MOB) today announces that a new terbinafine supplier has been secured for

Read full article »
Moberg Pharma's Competitors | Moberg Pharma's News | Moberg Pharma's Financials
Stay up-to-date with the latest news on Moberg Pharma
Annual Revenue
$25-100M
Employees
25-100
Anna Ljung's photo - CEO of Moberg Pharma

CEO

Anna Ljung

CEO Approval Rating

96/100

Read more
Stay up-to-date with the latest news on Moberg Pharma